Dr. Gerri Tobytha Byrd, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 10 Severance Cir, Cleveland Heights, OH 44118 Phone: 216-524-7377 Fax: 216-297-2751 |
News Archive
A new technology with research and clinical application including the early detection of disease has been invented and developed by University of Queensland researchers.
Merck & Co., Inc. will hold its third-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 9:00 a.m. EDT on Thursday, Oct. 22. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck's financial performance for the quarter.
Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
The American Cancer Society (ACS) and other preventive guideline organizations recommend that screening for colorectal cancer start for people of average risk at age 50.
A new article in Journal of Neurophysiology reports that professional ballet dancers have more control over their muscles than individuals with no dance training. Researchers from Emory University and Georgia Institute of Technology found that ballet training optimized muscle coordination not only for dancing but also everyday movements.
› Verified 3 days ago